Earth Science Tech, Inc. (ETST



DORAL, FL, 07 Oct 2021 (GLOBE NEWSWIRE) – Earth Science Tech, Inc. (ETST) (“ETST” or the “Company”), an innovative biotechnology company specializing in the nutraceutical and pharmaceutical fields, and devices Medical, today announces its planned acquisition structure with, LLC. (“RxCS”), Peaks Curative, LLC. (“PC”) and JCR Medical Equipment (“JCR”), Inc. as part of the Company’s new direction announced earlier this week.

The Company has discussed and plans to complete the acquisition of the three companies in a two-phase transaction using a mix of cash and ETST common stock. By structuring the acquisitions into two distinct phases, the Company will allow target companies the time necessary to effectively integrate their operations with the Company and among themselves. In addition, the Company believes that planning acquisitions over a slightly longer period will allow the Company to maintain the integrity of the shares, thereby maximizing shareholder value.

Phase I includes RxCS and PC, positioning the Company with operations in the pharmaceutical preparation industry, telemedicine industry, and erectile dysfunction industry, these industries have a planned collective valuation of over $ 73,000,000,000 and an average CAGR of 11.5% by 2028. Phase I is scheduled to begin in October 2021.

The acquisition of JCR as part of phase II will position the Company with activities in both the durable medical equipment industry and long-term care sector, these industries have a planned collective valuation of over $ 1,000,000,000 and an average CAGR of 6.4% by 2028. Phase II is expected to begin in the year 2022.

Once acquired, each company will become a wholly owned subsidiary of Earth Science Tech, Inc. and the Company will effect a name and stock symbol change in the near future to better reflect the change in business focus and more accurately represent the collective activities of the combined companies.

As the Company progresses with its Phase I acquisition during October 2021, Hygeeâ„¢, the Company medical device, owned by Earth Science Pharmaceutical, Inc., will be the subject of final discussions as the Company seeks a mutual agreement with its former partners to successfully license and commercialize Hygeeâ„¢. Marketing Hygeeâ„¢ position the Company with operations in the Medical device industry with an estimated valuation of over $ 671,000,000 and a CAGR of 5.2% by 2027.

Nickolas S. Tabraue, CEO of ETST, comments: “I feel with our 6 year history of working with our established network of doctors and clinics selling CBD products, as well as working with scientists and channels of international distribution developing Hygeeâ„¢, our acquisition objectives are well aligned in synergy with the ETST to collectively achieve greater revenues than any of them individually. As noted earlier this week, we are now able to rebuild and bounce back stronger than ever before and plan to do so with the addition of these carefully selected acquisition opportunities. “

About, LLC., LLC, is a compounding pharmacy that has focused on men’s health, specifically medical products for erectile dysfunction such as Tadalfil and Sildenafil Citrate (the generic names of Cialis and Viagra, respectively) and others. RxCS is not currently a “sterile compounding pharmacy”, but is in the process of obtaining the necessary licenses to supply sterile products for injection.

To learn more, please visit:

About Peaks Curative, LLC.

Peaks Curative, LLC., Is the leading telemedicine site to facilitate asynchronous consultations for brand name compound drugs prepared at RxCS. PC is currently in the final stages of completing its website and marketing campaign to launch in November / December.

About JCR Medical Equipment, Inc.
JCR Medical Equipment, Inc., is a sustainable medical equipment company (“DME”), a long-term care and retail pharmacy that has been in business since 1997. JCR recently began operating at Unified Care Service and reopened its retail pharmacy. to cross-sell to EMR clients / refer their medications. JCR is expanding its business in central Florida and plans to add 3 more hubs by 2023. From there, the company is looking to add home health services as it is about a logical complementary business segment that will not only provide additional cross-selling opportunities. clients / patients.
To learn more, please visit:

About Earth Science Tech, Inc. (ETST, Financial)
Earth Science Tech, Inc. (“ETST”) has changed its immediate focus to research and develop innovative hemp extracts and make them accessible worldwide; with the intention of being a supplier of high quality hemp oil enriched with high quality CBD. Its main goal was to advance various high quality hemp extracts with a broad profile of cannabinoids and additional natural molecules found in industrial hemp and to identify their distinct properties. Initially, our missions were to educate the public on the many and varied nutritional and health benefits of CBD-rich hemp oil, to optimize formulation purity and to find new product delivery systems. With the decline in sales of CBD due to the number of factors described in the Licensee’s periodic report filed with the SEC on Form 10-K for the period ending March 31, 2021, we have determined that the most effective way is to increase shareholder value would be the acquisition of a complementary business that would bring in sufficient income to support its own operations, but which would allow the business to grow and the Company to rebuild its CBD business.

To learn more, please visit:

PORT SAFETY ACT: Forward-looking statements are understood within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial condition, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, management plans and objectives for future operations, our listing in the CSE, including words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend to” , “May”, “could”, “should”, “shall” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause so that the actual results, performance or achievements differ materially from the anticipated results, performance or achievements. We have no obligation (and expressly disclaim any obligation to) update or change our forward-looking statements, whether as a result of new information, future events or otherwise.

Company details :
Nickolas S. Tabraue
CEO, President and Director



Leave A Reply

Your email address will not be published.